|
GFP Researchers Awarded Nobel Prizes
This year's Nobel Prize in Chemistry rewards the initial discovery of green fluorescent protein and a series of important developments, which have led to its use as a tagging tool in bioscience.
...continue
Molecule Coordinates Movement of Cells
Scientists at Rockefeller University have demonstrated that a molecule, ACF7, helps regulate and power cellular movement from the inside, findings that could have implications for understanding how cancer cells metastasize.
...continue
Structure of Adenosine Receptor Defined
Scientists from The Scripps Research Institute have determined the structure of an adenosine receptor that plays a critical role in a number of important physiological processes including pain, breathing, and heart function.
...continue
|
|
More Headlines
|
|
 |
Cell Culture Observation
The BioStation CT allows imaging experiments to be conducted without removing the cells from the incubator. Get a "bird's eye" color macro view from above. ... continue |
|
|
|
|
|
Brave New R&D World
 Is “virtual man” science fiction or a scientific necessity for drug development? Bioinformatics, systems biology and other disciplines may open the door to shorter research cycles and, ultimately, a digital view of how the human body and drugs interact.
...continue
|
|
|
 Policy & Projections
Down on the Pharm
 Research into producing inexpensive, plant-based therapeutic proteins, antibodies, and vaccines is making quiet progress, yet commercialization remains to be seen due to environmental opposition, high R&D costs, and regulatory and industry uncertainty.
...continue
|
Technology Advances
in vitro Analysis of Neurons
 Tracking normal development and disease pathways in the nervous system creates challenges at least as complex as the network of 100 billion neurons in the human brain. New products help researchers unravel what neurons do.
...continue
|
|
Technology in Action: The Hunt for miRNA
The discovery of microRNA opened new doors for drug research. Now, tools are helping researchers study even more regulatory RNA molecules.
...continue
Managing LC Variables
Developers of new methods for liquid chromatography battle a range of variables: buffer concentration, flow rate, reagents, and more.
...continue
Waters Unveils Mass Spec, Separations Science Tools
 Waters Corporation unveiled several new mass spectrometry innovations at the 56th American Society for Mass Spectrometry Conference including the Waters XevoTM TQ MS System.
...continue
Desktop Drugs
in silico predictions establish a beachhead in the war on cancer.
...continue
It's Tox Season
ADME-Tox gets a new face as more efficient systems are brought on board and collaborations with regulators ensue.
...continue
The Blockbuster Alternative
 Information-based medicine maps a model for targeted drug therapies using biomarkers, modeling and simulation, and adaptive clinical trials.
...continue
Modeling and Simulation Software
Accelrys, Inc., San Diego, Calif., announced the release of Discovery Studio 2.0, a modeling and simulation software environment for drug discovery.
...continue
|
|
More Technology Spotlight
|
|
|
Immnotherapy Welcomes TLR7
Researchers attempting to establish immunotherapies have been challenged when dosing with TLR agonists. With a better understanding of how to optimize the schedule of administering TLR7 agonists in different disease states, they may be able to sculpt the immune response appropriately for different diseases.
...continue
Lilly to Acquire ImClone Systems
Eli Lilly and Company and ImClone Systems Inc. announced a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5 billion.
...continue
Emerging Trends in Cell Biology Research 2008
 Drug Discovery & Development and Bioscience Technology magazines asked drug and life science researchers about current practices, trends, and research challenges in cell biology. What are the top technical challenges? Are funding levels adequate?
...continue
in vitro Analysis of Neurons
Tracking normal development and disease pathways in the nervous system creates challenges at least as complex as the network of 100 billion neurons in the human brain. New products help researchers unravel what neurons do.
...continue
Down on the Pharm
Research into producing inexpensive, plant-based therapeutic proteins, antibodies, and vaccines is making quiet progress, yet commercialization remains to be seen due to environmental opposition, high R&D costs, and regulatory and industry uncertainty.
...continue
|
|
More Recommended Reading
|
|
 Survey Says …
How important is technology in your research process? We asked life science researchers. See what they had to say—and how your facility compares in the 2008 Life Science Technology Trends Reader Survey. Read now…
|
|
|
|
 A report on the state of science in universities and colleges, from Advantage Business Media’s Science Group Read now …
|
|
|
|
Drug developers turn to the new and established immunoassay platforms to measure and identify protein biomarkers.
The drug discovery and development environment is occupied by different species of contract research organizations. What types will best serve your organization?
GE Healthcare introduces the Biacore T100 Immunogenicity Package, software that supports screening, confirmation, and characterization of anti-drug antibodies during the preclinical and clinical drug development process.
Automation, new detection methods give the old favorite Western blotting a new look.
Beckman Coulter released an advanced version of its eXPert software for the Optima L-XP Series Ultracentrifuges used in proteomics, cytomics, and genomics discovery research.
